CORPORATE NEWS

Clinical Results Show Divine 9 is a Breakthrough in HPV Prevention

March 11, 2019

New research results from the McGill University Medical School now shows that women can reduce the risk of contracting cancer-causing HPV infections by using Divine 9® personal lubricant with its proprietary CarraShield® sea algae extract.  The McGill team has studied the long term use of Divine 9 by hundreds of women.  The McGill team found that using Divine 9 personal lubricant in each intimate encounter significantly reduced the number of new HPV infections as compared to using a standard lubricant.

Revolutionary Study on Preventing Transmission of Cancer-causing HPV Using CarraShield Labs' Divine 9 Lubricant Launches at Rutgers and Albert Einstein Medical Schools

February 16, 2017

Distinguished research teams at Rutgers University New Jersey Medical School and Albert Einstein College of Medicine have launched a new study on preventing transmission of cancer-causing HPV during sexual activity using Divine 9® personal lubricant, which is made with a proprietary sea algae extract called CarraShield®. The researchers selected Divine 9 based on results from earlier National Cancer Institute laboratory testing that showed CarraShield prevented HPV transmission.

January 06, 2016

CarraShield Labs, Inc. announced today the U.S. Food and Drug Administration (FDA) has completed its evaluation of Divine 9® personal lubricant made with CarraShield™ and has authorized it to be marketed as a Class II Medical Device. Divine 9 with CarraShield is the first and only personal lubricant formulated with carrageenan, a type of sea algae extract, to be FDA-approved. The official notification can be found on the FDA website.

1 / 3

Please reload

PRESS COVERAGE

 

WHAT PEOPLE ARE SAYING...

1/4

CONNECT WITH DIVINE 9

  • Facebook Classic
  • Twitter Classic

CONTACT CARRASHIELD LABS WITH QUESTIONS, SUGGESTIONS OR ISSUES AND WE WILL BE GLAD TO HELP

© 2000-2017 CarraShield Labs, Inc.